Notable Tuesday Option Activity: SNDK, ELV, DAR

Elevance Health (ELV) saw options volume of 6,955 contracts (≈695,500 underlying shares), equal to about 56.6% of its one‑month average daily volume (1.2M shares); notable activity included 618 contracts in the $270 put expiring Feb 20, 2026 (≈61,800 shares). Darling Ingredients (DAR) recorded 12,367 option contracts (≈1.2M underlying shares), roughly 56% of its one‑month ADTV (2.2M shares), with heavy flow in the $45 Feb 20, 2026 call (5,372 contracts, ≈537,200 shares). These flows represent sizeable positioning relative to each stock’s typical liquidity and may signal concentrated directional bets or hedges ahead of the February 2026 expirations.

Analysis

Market structure: The outsized option flows (DAR: ~537,200 underlying shares; ELV: ~61,800) equal ~56% of each stock’s one‑month ADV, implying dealer hedging will temporarily add directional spot flow — likely upward pressure into DAR and downward pressure into ELV over days-to-weeks as market makers delta-hedge. Benefit accrues to holders of DAR equity/call buyers and to liquidity providers who capture bid/offers; longer-term holders of ELV risk mark‑to‑market pain if flows persist. Cross-asset: DAR is exposed to commodity and biofuel price moves so rising crude/tallow will amplify equity upside; ELV’s moves could modestly affect high‑grade credit spreads and healthcare sector beta versus yields.

Risk assessment: Tail risks include sudden regulatory shocks (CMS reimbursement or EPA RVO adjustments) that can move ELV or DAR >20% in weeks, and operational outages at DAR plants. Immediate (days) gamma hedging dominates; short-term (weeks–months) earnings/policy catalysts matter; long-term (to Feb 2026) flows may be parts of structured positions or M&A hedges. Hidden dependency: single‑strike concentration suggests block trade or structured collar — do not assume naked directional exposure without IV/position color. Key catalysts: earnings windows (next 30–90 days), EPA RVO announcements, large crude moves (>10%).

Trade implications: Direct: favor a tactical long DAR call‑spread to capture bullish flow while limiting IV risk (use Feb 20, 2026 expiries). For ELV, prefer limited‑risk bearish exposure via put spreads or buying protection rather than naked shorts. Pair trade: dollar‑neutral long DAR / short ELV sized 1% each to exploit divergent sentiment; close or rebalance if either leg moves >20% or on next earnings release. Entry window: scale in over 2–6 weeks while monitoring IV and block trade follow‑through.

Key Decisions for Investors

• Establish a 1.5% portfolio long in DAR via a Feb 20, 2026 $45/$60 call debit spread (buy $45, sell $60) to cap premium outlay; target 40–80% absolute return if DAR rallies 25–50% by expiry, max loss = premium paid. Enter within 2–6 weeks while open interest confirms follow‑through.
• Take a defensive 1–2% position on ELV by buying a Feb 20, 2026 $270/$240 put spread (debit) to limit downside cost; close if ELV implied volatility rises >30% above 30‑day average or if put spread trades to <20% of max value, otherwise hold to expiry or until earnings (whichever first).
• Implement a dollar‑neutral pair: long DAR equity (1% AUM) and short ELV equity (1% AUM); trim/close the pair if either leg moves >20% or after the next scheduled earnings for that company. Reassess after EPA RVO publication or CMS announcements within 60–90 days.
• If DAR 30‑day implied volatility falls >15% post‑entry, consider selling 1–2 month OTM puts (for <1% downside risk per trade) to finance additional call spread purchases; avoid naked short exposure if put delta >0.25 or IV >40%.